Zinc ligand-disrupted recombinant human Endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile.
- 1 January 1999
- journal article
- Published by Springer Nature in Angiogenesis
- Vol. 3 (1) , 41-51
- https://doi.org/10.1023/a:1009058931769
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: